May 8, 2026 06:08AM

Mar 5, 2024 11:54PM

Mar 5, 2024 11:53PM

Mar 4, 2024 04:18PM

Mar 4, 2024 04:17PM

Feb 2, 2024 07:00AM

Nov 2, 2023 05:00PM Form S-3ASR BridgeBio Pharma, Inc.

Nov 2, 2023 07:30AM

Oct 9, 2023 07:30AM

Jul 26, 2023 04:07PM

May 4, 2023 04:58PM

Mar 21, 2023 07:30AM

Mar 8, 2023 07:01AM

Mar 8, 2023 07:00AM BridgeBio Pharma Announces Pricing of Public Offering of Common Stock

Mar 8, 2023 07:00AM

Mar 6, 2023 04:06PM

Mar 6, 2023 04:06PM

Mar 6, 2023 04:05PM

Mar 6, 2023 04:05PM

Mar 8, 2022 07:30AM

May 28, 2021 02:33PM BridgeBio Pharma (BBIO) Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ for Patients with Cholangiocarcinoma

Feb 12, 2021 08:04AM

Feb 12, 2021 08:00AM

Feb 12, 2021 08:00AM

Feb 11, 2021 04:12PM

Feb 11, 2021 04:10PM

Feb 11, 2021 04:09PM

Feb 11, 2021 04:09PM BridgeBio Pharma, Inc. Announces Launch of Secondary Offering of Common Stock

Nov 13, 2020 07:35AM

May 6, 2020 08:22PM

May 5, 2020 04:06PM

Jun 27, 2019 06:27PM

70,526 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All